New Generation of Meso and Antiprogestins (SPRMs) into the Osteoporosis Approach
Receptor activator of nuclear factor κB (RANK) and its ligand (RANKL) play key roles in bone metabolism and the immune system. The RANK/RANKL complex has also been shown to be critical in the formation of mammary epithelia cells. The female hormones estradiol and progesterone closely control the act...
Guardado en:
Autores principales: | Magdalena Woźniczka, Katarzyna Błaszczak-Świątkiewicz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7b10aaf7ac6e4049a35883c746c27a12 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
por: Anne-Priscille Trouvin, et al.
Publicado: (2010) -
Emerging treatments for postmenopausal osteoporosis – focus on denosumab
por: Piet Geusens
Publicado: (2009) -
Comprehensive Transcriptomic Profiling of Murine Osteoclast Differentiation Reveals Novel Differentially Expressed Genes and LncRNAs
por: Salman M. Toor, et al.
Publicado: (2021) -
Enfrentamiento de la osteoporosis post menopáusica en la consulta ginecológica
por: Francisco,Fuentes Q, et al.
Publicado: (2017) -
Changes in Bone Metabolism and Structure in Primary Hyperparathyroidism
por: Yankova I., et al.
Publicado: (2020)